Welcome to My Blog
Here is a masonry blog layout with no sidebarUnderwriters puzzle over how to make pandemics insurable again
U.S. company SpottedRisk has devised a model built on years of data on the political and economic environment of film locations in 150 countries, as well as a year’s COVID-19 shutdown data, to come up with a pricing mechanism to cover the risk of production stopping due to the pandemic.
Britain, the European Union and the United States are all looking at arrangements in which cover from commercial insurers would be backed by government reinsurance schemes. Such schemes could be less costly than business bailouts but the process of developing them is slow, as governments grapple with the problems at hand.
Europe dares to reopen as 200 millionth vaccine dose delivered
Insurers can’t deny Carona covers to customers: IRDAI
Non-life insurance cos register 22 pc growth in gross premium at Rs 17,310 cr in Apr
Alamelu panel suggests 2 new Title Insurance products
China’s population growth slows; nation becomes older and urbanised
Rail union demands compensation on a par with frontline workers in case of death on duty during Covid
In a letter to Railway Minister Piyush Goyal, general secretary of the All India Railwaymen’s Federation Shiva Gopal Mishra said around 1,500 railway staffers died during the pandemic while more than one lakh have been infected by the virus.
He said that more than 65,000 have recovered and joined their duties again, adding while a letter of appreciation from the minister lauding their dedication was encouraging, a parity in compensation would be of great help for the families.
Positive COVID-19 test report not mandatory for admission in hospitals: Govt
“Hospitals under the central government, state governments and UT administration, including private hospitals managing COVID patients, shall ensure that requirement of a positive test for COVID-19 virus is not mandatory for admission to a COVID health facility.
“A suspect case shall be admitted to the suspect ward of COVID Care Centre (CCC), Dedicated COVID Health Centre (DCHC) of Dedicated COVID Hospital (DHC) as the case may be,” the directive to all the states and Union Territories said.
Online flood reporting system launched in Assam
UNICEF India Chief, Emergency and Disaster Risk Reduction (DRR), Tom White congratulated the Assam government for being the first state to adopt the digital reporting system that will capture critical impact indicators during floods.
”Such a system will go a long way in measuring the impact of disaster risk reduction interventions,” he said.
India’s daily COVID-19 deaths near record, calls for nationwide lockdown mount
The Indian Medical Association (IMA), the umbrella body for all conventional doctors and surgeons, called for a “complete, well-planned, pre-announced” lockdown across the country instead of “sporadic” night curfews and restrictions imposed by states for a few days at a time.
“IMA is astonished to see the extreme lethargy and inappropriate actions from the ministry of health in combating the agonizing crisis born out of the devastating second wave of the COVID-19 pandemic,” it said in a statement on Saturday.
Variant accelerating India’s Covid-19 explosion: WHO top scientist
The surge in India is frightening not only due to the horrifying number of people who are sick and dying there, but also because the exploding infection numbers dramatically increase the chances of new and more dangerous variants emerging.
“The more the virus is replicating and spreading and transmitting, the more chances are that… mutations will develop and adapt,” Swaminathan said.
Pharma has limited legal options if vaccine patents waived
Still, some vaccine producers, like Moderna Inc. and Pfizer Inc., might sue the U.S. to recoup some of their losses, said Matthew Howell, an intellectual property attorney at Alston & Bird in Atlanta. If the manufacture of the vaccine is done in the U.S., under the government’s authorization, there are avenues for compensation in American courts.
EU to discuss US vaccine patent plan
The move to support waiving intellectual property protections on vaccines under World Trade Organization rules marked a dramatic shift for the United States, which had previously lined up with many other developed nations opposed to the idea floated by India and South Africa.
While the EU did not echo the U.S. position, it generally welcomed President Joe Biden’s move.
EU top court upholds ban on Bayer pesticides linked to harming bees
The Commission in 2013 restricted the use of the neonicotinoids, meaning they could not be used on maize, rapeseed and some spring cereals. They could still be used for other crops, such as sugar beet.
The Commission had reviewed the approvals because of the loss of bee colonies due to the misuse of pesticides.
Tokyo Games need 500 nurses; nurses say needs are elsewhere
French banks told to speed up response to climate change
Other financial watchdogs around the world will also be conducting similar tests on the finance industry to help to reduce the impact of climate change on economies. Banks and other finance companies will have to disclose to investors the impact of climate change on their balance sheets under proposed European Union rules.
Insurers warn government Canada’s flood mapping must not take a decade
Prime Minister Justin Trudeau pledged sweeping climate action during his re-election campaign last year, including C$150 million ($112.2 million) for flood mapping. The federal budget is expected at the end of March.
“Flooding is by far the single greatest peril facing Canadians as a result of climate change,” Craig Stewart, vice president of federal affairs for the Insurance Bureau of Canada, told Reuters.
WHO experts voice “very low confidence” in some Sinopharm COVID-19 vaccine data
The document includes summaries of data from clinical trials in China, Bahrain, Egypt, Jordan and the United Arab Emirates.
The “evidence assessment” document was prepared by the WHO’s Strategic Advisory Group of Experts (SAGE) for its evaluation of the Sinopharm shot, authorised by 45 countries and jurisdictions for use in adults, with 65 million doses administered. The experts review evidence and give recommendations on policy and dosages associated with a vaccine.